Negative prognostic influence of micropapillary pattern in stage IA lung adenocarcinoma

被引:46
|
作者
Tsubokawa, Norifumi [1 ]
Mimae, Takahiro [1 ]
Sasada, Shinsuke [1 ]
Yoshiya, Tomoharu [1 ]
Mimura, Takeshi [1 ]
Murakami, Shuji [2 ]
Ito, Hiroyuki [3 ]
Miyata, Yoshihiro [1 ]
Nakayama, Haruhiko [3 ]
Okada, Morihito [1 ]
机构
[1] Hiroshima Univ, Dept Surg Oncol, 1-2-3 Kasumi, Hiroshima 7348551, Japan
[2] Kanagawa Canc Ctr, Dept Resp Med, 1-1-2 Nakao, Yokohama, Kanagawa 2410815, Japan
[3] Kanagawa Canc Ctr, Dept Thorac Surg, 1-1-2 Nakao, Yokohama, Kanagawa 2410815, Japan
基金
日本学术振兴会;
关键词
Lung cancer; Micropapillary; Prognosis; DISTINCT PATHOLOGICAL MARKER; HISTOLOGIC SUBTYPE; PULMONARY ADENOCARCINOMA; POOR-PROGNOSIS; EGFR MUTATIONS; COMPONENT; BRONCHIOLOALVEOLAR; PAPILLARY; ASSOCIATION; EXPRESSION;
D O I
10.1093/ejcts/ezv058
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: There is uncertainty as to which factors determine the aggressiveness of lung adenocarcinoma with a micropapillary pattern (MPP). The present study aimed to clarify the influence of a MPP on the malignant aggressiveness of clinical stage IA lung adenocarcinoma. METHODS: We retrospectively examined 347 consecutive patients with clinical stage IA lung adenocarcinoma who underwent complete resection. We defined MPP-positive as accounting for >= 5% of the entire tumour. RESULTS: Forty-eight (14%) and 299 (86%) patients were MPP-positive and negative, respectively. Lymphatic (P = 0.003) and vessel (P = 0.029) invasion as well as lymph node metastasis (P = 0.002) were more frequent in the MPP-positive than negative group. Five-year disease-free survival (DFS) rates were significantly lower in the MPP-positive than negative group (69.7 vs 89.3%, P < 0.001). Multivariate analysis for DFS showed that MPP (P = 0.048), lymphatic invasion (P = 0.003) and vessel invasion (P = 0.002) were independent poor prognostic factors. In addition, higher proportions (<5%, 5-30% and >= 30%) of MPP were associated with a poorer prognosis (89.3, 76.0, and 48.1%, respectively; P < 0.001). The prognosis of patients with MPP-positive tumours and negative tumours harbouring lepidic and solid predominant growth patents did not differ (100 vs 96.8%, P = 0.564; 66.7 vs 62.5%, P = 0.791, respectively). On the other hand, the prognosis tended to be poorer for patients with papillary predominant MPP-positive tumours than for those with negative tumours (62.5 vs 82.5%, P = 0.075). CONCLUSIONS: MPP has an effect on tumour malignancy and patients with tumours harbouring a higher ratio of MPP or papillary predominant subtypes have worse survival.
引用
收藏
页码:293 / 299
页数:7
相关论文
共 50 条
  • [1] Prognostic significance of micropapillary and solid patterns in stage IA lung adenocarcinoma
    Peng, Bin
    Li, Guofeng
    Guo, Yanhua
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (09): : 10562 - 10569
  • [2] Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma
    Kamiya, Kazunori
    Hayashi, Yuichiro
    Douguchi, Junya
    Hashiguchi, Akinori
    Yamada, Taketo
    Izumi, Yotaro
    Watanabe, Masazumi
    Kawamura, Masafumi
    Horinouchi, Hirohisa
    Shimada, Naoki
    Kobayashi, Koichi
    Sakamoto, Michiie
    MODERN PATHOLOGY, 2008, 21 (08) : 992 - 1001
  • [3] A prognostic nomogram based on a new classification of combined micropapillary and solid components for stage IA invasive lung adenocarcinoma
    Huang, Wuhao
    Zhang, Hua
    Zhang, Zhiwei
    Zhang, Bin
    Sun, Xiaoyan
    Huo, Yansong
    Feng, Yingnan
    Tian, Pengfei
    Mo, Huilan
    Wang, Changli
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 125 (04) : 796 - 808
  • [4] Micropapillary Predominant Lung Adenocarcinoma in Stage IA Benefits from Adjuvant Chemotherapy
    Wang, Cong
    Yang, Jinguo
    Lu, Ming
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (06) : 2051 - 2060
  • [5] Micropapillary Predominant Lung Adenocarcinoma in Stage IA Benefits from Adjuvant Chemotherapy
    Cong Wang
    Jinguo Yang
    Ming Lu
    Annals of Surgical Oncology, 2020, 27 : 2051 - 2060
  • [6] Micropapillary pattern of stage IIIA-N2lung adenocarcinoma is a prognostic factor after adjuvant chemoradiotherapy
    Zeng, Jian
    Cui, Xiaoying
    Cheng, Lei
    Chen, Ying
    Du, Xianghui
    Sheng, Liming
    FUTURE ONCOLOGY, 2020, 16 (36) : 3075 - 3084
  • [7] Does the presence of a micropapillary component predict worse prognosis in pathological stage IA lung adenocarcinoma?
    Wang, Yan
    Song, Wenpeng
    Wang, Xin
    Che, Guowei
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 242
  • [8] Clinicopathological Significance of Micropapillary Pattern in Lung Adenocarcinoma
    Pyo, Jung-Soo
    Kim, Joo Heon
    PATHOLOGY & ONCOLOGY RESEARCH, 2018, 24 (03) : 547 - 555
  • [9] Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma
    Qian, Fangfei
    Yang, Wenjia
    Wang, Rui
    Xu, Jianlin
    Wang, Shuyuan
    Zhang, Yanwei
    Jin, Bo
    Yu, Keke
    Han, Baohui
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (03): : 1227 - +
  • [10] Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components
    Li, Rongyang
    Qiu, Jianhao
    Li, Zhenyi
    Li, Haiming
    Tang, Zhanpeng
    Yu, Wenhao
    Tian, Hui
    Sun, Zhenguo
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)